These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10223328)

  • 1. Chimeric virus-like particles as vaccines.
    Krüger DH; Ulrich R; Gerlich WH
    Biol Chem; 1999 Mar; 380(3):275-6. PubMed ID: 10223328
    [No Abstract]   [Full Text] [Related]  

  • 2. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
    Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
    Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
    Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies.
    Gil F; Titarenko E; Terrada E; Arcalís E; Escribano JM
    Plant Biotechnol J; 2006 Jan; 4(1):135-43. PubMed ID: 17177792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric Newcastle disease virus nucleocapsid with parts of viral hemagglutinin-neuraminidase and fusion proteins.
    Rabu A; Tan WS; Kho CL; Omar AR; Yusoff K
    Acta Virol; 2002; 46(4):211-7. PubMed ID: 12693857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus.
    Gromadzka B; Szewczyk B; Konopa G; Fitzner A; Kesy A
    Acta Biochim Pol; 2006; 53(2):371-6. PubMed ID: 16733562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
    Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and the immunogenicity of the recombinant Modified Vaccinia Virus Ankala co-expressing ORF4, ORF5 and ORF6 genes of porcine reproductive and Respiratory Syndrome Virus NJ-a strain].
    Zheng QS; Bi ZX; Li P; Chen DS; Chen PY
    Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):345-9. PubMed ID: 17552247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
    Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
    Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like particles: a new family of delivery systems.
    Boisgérault F; Morón G; Leclerc C
    Expert Rev Vaccines; 2002 Jun; 1(1):101-9. PubMed ID: 12908517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.
    Peacey M; Wilson S; Baird MA; Ward VK
    Biotechnol Bioeng; 2007 Dec; 98(5):968-77. PubMed ID: 17546687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology evaluation: HspE7, StressGen Biotechnologies Corp.
    Hunt S
    Curr Opin Mol Ther; 2001 Aug; 3(4):413-7. PubMed ID: 11525566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine.
    Wu JQ; Barabé ND; Chau D; Wong C; Rayner GR; Hu WG; Nagata LP
    Vaccine; 2007 May; 25(22):4368-75. PubMed ID: 17467858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma.
    Wong CP; Levy R
    Cancer Res; 2000 May; 60(10):2689-95. PubMed ID: 10825142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection.
    Neilan JG; Zsak L; Lu Z; Burrage TG; Kutish GF; Rock DL
    Virology; 2004 Feb; 319(2):337-42. PubMed ID: 14980493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of humoral and cellular immune responses against the nucleocapsid of bovine viral diarrhea virus by an adenovirus vector with an inducible promoter.
    Elahi SM; Shen SH; Talbot BG; Massie B; Harpin S; Elazhary Y
    Virology; 1999 Aug; 261(1):1-7. PubMed ID: 10441551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.